Glenmark Pharmaceuticals Limited (GLENMARK)
After trading with bearish bias for over a week, GLENMARK posted decent recovery from day’s low on 16th February and settled near day’s high, indicating buyer’s interest at current levels. Early signs of recovery are also visible on the daily chart. Considering all, we recommend buying this stock.
Buy Glenmark Pharmaceuticals Limited @ 926-930 Stoploss 905 Target 980 CMP 931.75
To Read Complete Report & Disclaimer Click Here
For Religare Securities Ltd Disclaimer http://old.religareonline.com/research/Disclaimer/Disclaimer_RSL.html
Above views are of the author and not of the website kindly read disclaimer